Join Now

Category Archives: BioUtah News

Utah Legislative Recap – February 15, 2024

By Natalie Themm | Published February 15, 2024

Utah Legislative Recap – Updated February 15, 2024

| Tagged | Comments Off on Utah Legislative Recap – February 15, 2024

Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd

By admin | Published February 9, 2024

LONDON and SALT LAKE CITY, February 9, 2024 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on February 8, 2024 the Centers for Medicare and Medicaid Services (“CMS”) published a draft Local Coverage Determination (“LCD”) for the Company’s KidneyIntelX and kidneyintelX.dkd testing. The draft LCD can be accessed at https://www.cms.gov/medicare-coverage-database/. The established Medicare price […]

| Comments Off on Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd

Utah Legislative Recap, Feb. 9, 2024

By admin | Published February 8, 2024

Funding Requests   Life Sciences Initiative – Senator Ann Millner The original initiative requested the legislature provide $7.125M of ongoing funding to higher education in Utah to support the workforce needs of Utah’s Life Sciences industry.  BioUtah has worked closely with Talent Ready Utah, colleges and universities in the state, and other stakeholders to create […]

| Comments Off on Utah Legislative Recap, Feb. 9, 2024

2024 Life Sciences Day on the Hill Recap

By admin | Published February 8, 2024

Utah’s vibrant life sciences industry was on full display February 7 as part of BioUtah’s “Life Sciences Day on the Hill”. The event, a collarboration with the Governor’s Office of Economic Opportunity, (GOEO) was held at the state capitol. 29 companies exhibited their innovative technologies in the capitol rotunda, which provided legislators the opportunity to […]

| Comments Off on 2024 Life Sciences Day on the Hill Recap

Eris Biotech accepted to Y Combinator

By Natalie Themm | Published February 8, 2024

Eris Biotech accepted to Y Combinator

| Tagged | Comments Off on Eris Biotech accepted to Y Combinator

Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

By Natalie Themm | Published February 8, 2024

Clene Inc. (NASDAQ: CLNN) Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

| Tagged | Comments Off on Clene Inc. Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

By Natalie Themm | Published February 8, 2024

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

| Tagged | Comments Off on Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

By Natalie Themm | Published February 8, 2024

This technology will support the development of Halia’s new Alzheimer’s disease drug, HT-4253, targeting a mediator of neuroinflammation called Leucine-rich repeat kinase 2 (LRRK2)

| Tagged | Comments Off on Halia Therapeutics Announces Collaboration with Canary Speech to Leverage its Cutting Edge AI- Driven Speech Technology to Advance the Clinical Development of Novel Therapeutics Targeting Neuroinflammation

AdvaMed Announces New Chair of State Medtech Alliance

By Natalie Themm | Published February 8, 2024

AdvaMed Announces New Chair of State Medtech Alliance

| Tagged | Comments Off on AdvaMed Announces New Chair of State Medtech Alliance

AI Utah Annouces Inaugural AI Utah 100 List

By Natalie Themm | Published February 1, 2024

AI Utah Annouces Inaugural AI Utah 100 List

| Tagged | Comments Off on AI Utah Annouces Inaugural AI Utah 100 List

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

By Natalie Themm | Published February 1, 2024

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

| Tagged | Comments Off on Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

By Natalie Themm | Published February 1, 2024

Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

| Tagged | Comments Off on Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health

A Special Thanks To Our Legacy and Platinum Elite Members